Clinical diagnostic value of serum soluble IL-2 receptor for stage I sarcoidosis in benign isolated mediastinal and hilar lymphadenopathy
Clinica Chimica Acta · 2023
DOI: 10.1016/j.cca.2023.117372 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinica Chimica Acta, 2023. Verfasst von Weili Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Ningbo University, Ningbo 315020, China; Department of Immunolog…. Hauptthemen laut MEDLINE: Sarcoidosis, Lymphadenopathy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Serum soluble interleukin-2 receptor (sIL-2R) is recognized as a marker of T-cell activation and is abnormally elevated in sarcoidosis. However, its value for stage I sarcoidosis in benign granulomatous diseases is unclear. METHODS: We enrolled 33 stage I sarcoidosis patients, 17 lymph node tuberculosis patients, 15 reactive lymphadenopathy patients, and 11 healthy controls. Serum biomarkers concentrations were collected and collated. RESULTS: Serum sIL-2R concentrations were the highest in stage I sarcoidosis. The AUC of serum sIL-2R for stage I sarcoidosis was 0.7452 in all subjects and 0.6861 in granulomatous diseases. The AUCs of two combined diagnostic forms, sIL-2R with angiotensin-converting enzyme (ACE) and sIL-2R with ACE, erythrocyte sedimentation rate (ESR), and lactate dehydrogenase (LDH) were 0.7994 and 0.891 in all subjects, respectively. In granulomatous disease groups for ROC analysis, the best cut-off value of sIL-2R was 745.00 U/ml with 48.50% sensitivity and 84.40% specificity. The combination of four parameters increased the diagnostic accuracy for stage I sarcoidosis in granulomatous diseases (74.10% sensitivity and 100% specificity). Serum sIL-2R concentrations were positively correlated with serum ACE (r = 0.4652, P = 0.0126). CONCLUSION: Serum sIL-2R appeared to be valuable in identifying stage I sarcoidosis in a group of benign granulomatous disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Ningbo University, Ningbo 315020, China; Department of Immunology, Zhejiang Key Laboratory of Pathophysiology, Health Science Center,…
- Department of Immunology, Zhejiang Key Laboratory of Pathophysiology, Health Science Center, Ningbo University, Ningbo 315211, China.
- Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Ningbo University, Ningbo 315020, China.
- Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Ningbo University, Ningbo 315020, China. Electronic address: dingqunli@nbu.edu.cn.
- Endoscopy Center, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China. Electronic address: Drsymons@outlook.com.
Zitieren
APA
Chen, W., Zhang, Q., Li, M., Huang, G., Guo, L., Chen, Z., Ding, Q., & Gu, Y. (2023). Clinical diagnostic value of serum soluble IL-2 receptor for stage I sarcoidosis in benign isolated mediastinal and hilar lymphadenopathy. Clinica Chimica Acta. https://doi.org/10.1016/j.cca.2023.117372
Vancouver
Chen W, Zhang Q, Li M, Huang G, Guo L, Chen Z, et al. Clinical diagnostic value of serum soluble IL-2 receptor for stage I sarcoidosis in benign isolated mediastinal and hilar lymphadenopathy. Clinica Chimica Acta. 2023. doi:10.1016/j.cca.2023.117372
BibTeX
@article{Chen2023,
author = {Chen, Weili and Zhang, Qipan and Li, Mingcai and Huang, Guoqing and Guo, Lun and Chen, Zhongbo and Ding, Qunli and Gu, Ye},
title = {Clinical diagnostic value of serum soluble IL-2 receptor for stage I sarcoidosis in benign isolated mediastinal and hilar lymphadenopathy},
journal = {Clinica Chimica Acta},
year = {2023},
doi = {10.1016/j.cca.2023.117372}
}
EUVIMED